Filgotinib may be associated with a lower risk of herpes zoster compared with other Janus kinase inhibitors in rheumatoid arthritis.

HSV type 1 reactivation was prevalent among critically ill patients with COVID-19 and was independently associated with ...

64 percent of people under 50 have HSV-1 – WHO’s report breaks down herpes symptoms, prevention, treatment, and why stigma is ...

Replimune announces favourable outcome from US FDA’s Advisory Committee meeting for RP1 in advanced melanoma: Woburn, Massachusetts Saturday, August 1, 2026, 16:00 Hrs [IST] Rep ...

TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI” or the “Company”), a Health IT company leveraging its artificial intelligence platform EinsteinRx ™ and ...

New research suggests the two-dose Shingrix vaccine could also lower the risk of dementia, adding to its benefits for adults ...

Herpetic infection signals differ across targeted therapies for patients with AD, including for overall and type-specific herpetic infections.

Japan: In an exploratory randomized trial from Japan, patients with rheumatoid arthritis who started the JAK inhibitor ...

Gürtelrose kann weit mehr sein als nur ein lästiger Ausschlag. Dermatologe Rainer Kunstfeld sagt, warum eine frühe Behandlung ...

IGNYTE showed that patients with confirmed progression on an anti-PD-1-based regimen who received RP1 plus nivolumab had a 34% response rate, with a median duration of 24.8 months, and 15% of them ...

A randomized trial in patients with rheumatoid arthritis (RA) suggests that the timing of when a Janus kinase (JAK) inhibitor ...

Is een bloedonderzoek voor je cholesterol of vitaminetekorten wel nodig? Het Riziv werkt aan strengere richtlijnen die artsen ...